Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp

Tropical Medicine and International Health

Volumn 1, Issue 3, 1996, Pages 385-392

  Haelterman, Edwige ^a,b   Boelaert, Marleen ^a,c   Suetens, Carl ^a   Blok, Lucie ^d   Henkens, Myriam ^a   Toole, Michael J ^e  

^a MÉDECINS SANS FRONTIÈRES   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

^e MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

active immunization; bacterial meningitis; epidemics; epidemiology; meningitis; meningococcal meningitis; Neisseria meningitidis; outbreaks; refugees; vaccination

Indexed keywords

CHLORAMPHENICOL; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; ARTICLE; BACTERIAL MENINGITIS; CHILD; DEMOCRATIC REPUBLIC CONGO; EPIDEMIC; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; PRISON; REFUGEE; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

BACTERIA (MICROORGANISMS); MENINGOCOCCUS; NEISSERIA MENINGITIDIS;

HEALTH IMPACT; MENINGITIS; REFUGEE CAMP; VACCINATION;

ZAIRE;

EID: 0029669888     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1996.d01-49.x     Document Type: Article

References (29)

1. Binkin N & Band J (1982) Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy. Lancet ii, 315-318.
2. Bosmans E, Vimont-Vicary P, André FE, Crooy PJ, Roelants P & Vandepitte J (1980) Protective efficacy of a bivalent (A + C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda. Annales de la Société belge de Médecine tropicale 60, 297-306.
3. Cadoz M (1984) Les méningites à méningocoque en Afrique. Leur prophylaxie vaccinale. Médecine d'Afrique Noire 31, 353-361.
4. Cochi SL, Markowitz LE, Joshi DD et al. (1987) Control of epidemic group A meningococcal meningitis in Nepal. International Journal of Epidemiology 16, 91-97.
5. Erwa HH, Haseeb MA, Idris AA, Lapeyssonnie L, Sanborn WR & Sippel JE (1973) A serogroup A meningococcal polysaccharide vaccine. Bulletin of the World Health Organization 49, 301-305.
6. Galazka A (1982) Meningococcal disease and its control with meningococcal polysaccharide vaccines. Bulletin of the World Health Organization 60, 1-7.
7. Goma Epidemiology Group (1995) Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July 1994? Lancet 345, 339-344.
8. Greenwood BM (1984) Selective Primary Health Care: Strategies for control of disease in the developing world. XIII. Acute bacterial meningitis. Reviews of Infectious Diseases 6, 374-389.
9. Greenwood BM (1987) The epidemiology of acute bacterial meningitis in tropical Africa. In Bacterial meningitis (eds Williams JD & Burnie J) Harcourt Brace Jovanovich, London, pp. 61-91.
10. Greenwood BM, Blakebrough IS, Bradley AK, Wali S & Whittle HC (1984) Meningococcal disease and season in sub-Saharan Africa. Lancet i, 1339-1342.
11. Mohammed I & Zaruba K (1981) Control of epidemic meningococcal meningitis by mass vaccination. Lancet ii, 80-83.
12. Moore PS (1991) Meningococcal meningitis in sub-Saharan Africa: A model for the epidemic process. Clinical Infectious Diseases 14, 515-525.
13. Moore PS, Hierholzer J, DeWitt W et al. (1990a) Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA 264, 1271-1275.
14. Moore PS, Plikaytis BD, Bolan GA et al. (1992) Detection of meningitis epidemics in Africa: a population-based analysis. International Journal of Epidemiology 21, 155-162.
15. Moore PS, Reeves MW, Schwartz B, Gellin BG & Broome CV (1989) Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet ii, 260-263.
16. Moore PS, Toole MJ, Nieburg P, Waldman RJ & Broome CV (1990b) Surveillance and control of meningococcal meningitis epidemics in refugee populations. Bulletin of the World Health Organization 68, 587-596.
17. Peltola H (1983) Meningococcal disease: Still with us. Reviews of Infectious Diseases 5, 71-91.
18. Peltola H, Mäkelä PH, Käyhty H et al. (1977) Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. The New England Journal of Medicine 297, 686-691.
19. Pinner RW, Onyango F, Perkins BA et al. (1992) Epidemic meningococcal disease in Nairobi, Kenya, 1989. Journal of Infectious Diseases 166, 359-364.
20. Reingold AL, Hightower AW, Bolan GA et al. (1985) Age-specific differences in duration of clinical protection after vaccination with menigococcal polysaccharide A vaccine. Lancet 2, 114-118.
21. Schwartz B, Moore PS & Broome CV (1989) Global epidemiology of meningococcal disease. Clinical Microbiology Reviews 2, S118-S124.
22. Spiegel A, Greindl Y, Lippeveld T et al. (1993) Effet de deux stratégies de vaccination sur l'évolution de l'épidémie de méningite à méningocoque A survenue à N'Djamena (Tchad) en 1988. Bulletin of the World Health Organization 71, 311-315.
23. Tikhomirov E (1987) Meningococcal meningitis: global situation and control measures. Rapport trimestriel des statististiques sanitaires mondiales 40, 98-109.
24. UNHCR (1986) Handbook for Emergencies. Geneva.
25. Vimont-Vicary P & Rogerie F (1983) Epidémie de méningite cérébrospinale à neisseria meningitidis dans la région sanitaire de Ruhengeri (Rwanda). Médecine Tropicale 43, 155-161.
26. Wali SS, MacFarlane JT, Weiz VRL (1979) Single injection treatment of meningococcal meningitis. 2 Long-acting chloramphenicol. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, 698-702.
27. Wills W, Greiel M & Tondeur G (1986) Le Kivu montagneux. Académie Royale des Sciences d'Outre-Mer, Bruxelles.
28. Wright PF (1989) Approaches to prevent acute bacterial meningitis in developing countries. Bulletin of the World Health Organization 67, 479-486.
29. WHO (1995) Control of epidemic meningococcal diseases. WHO Practical Guidelines.